Published in Cell on November 16, 1990
Ras oncogenes: split personalities. Nat Rev Mol Cell Biol (2008) 7.91
Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science (2002) 5.08
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev (2001) 4.68
Antioncogenes and human cancer. Proc Natl Acad Sci U S A (1993) 4.09
Human RAS superfamily proteins and related GTPases. Sci STKE (2004) 3.80
Mouse tumor model for neurofibromatosis type 1. Science (1999) 2.89
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet (2005) 2.85
A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A (1995) 2.70
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol (2002) 2.65
Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet (2003) 2.56
Insulin stimulation of gene expression mediated by p21ras activation. EMBO J (1991) 2.23
Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein alpha subunit). Mol Cell Biol (1996) 2.20
Deregulated Ras signaling compromises DNA damage checkpoint recovery in S. cerevisiae. Cell Cycle (2010) 2.05
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene (2007) 1.97
Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity. Mol Cell Biol (1992) 1.93
Hydrolysis of GTP by Sec4 protein plays an important role in vesicular transport and is stimulated by a GTPase-activating protein in Saccharomyces cerevisiae. Mol Cell Biol (1992) 1.90
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development (2005) 1.85
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
The Princeton Protein Orthology Database (P-POD): a comparative genomics analysis tool for biologists. PLoS One (2007) 1.83
How does the Schwann cell lineage form tumors in NF1? Glia (2008) 1.63
Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol Cell Biol (1991) 1.62
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet (2013) 1.60
Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma. Cancer Cell (2014) 1.57
Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet (1997) 1.55
Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc Natl Acad Sci U S A (1993) 1.55
Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A (1991) 1.55
Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1991) 1.44
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras. Mol Cell Biol (1993) 1.41
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer (2015) 1.40
The Saccharomyces cerevisiae SDC25 C-domain gene product overcomes the dominant inhibitory activity of Ha-Ras Asn-17. Mol Cell Biol (1993) 1.39
A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions. Mol Cell Biol (1994) 1.39
Two types of RAS mutants that dominantly interfere with activators of RAS. Mol Cell Biol (1994) 1.36
Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol Cell Biol (1997) 1.33
Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet (2007) 1.33
Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. J Biol Chem (2000) 1.32
Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function. Mol Cell Biol (1993) 1.31
Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J (1998) 1.30
Localization of the rap1GAP catalytic domain and sites of phosphorylation by mutational analysis. Mol Cell Biol (1992) 1.29
Advances in the treatment of neurofibromatosis-associated tumours. Nat Rev Clin Oncol (2013) 1.26
The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res (1996) 1.21
sar1, a gene from Schizosaccharomyces pombe encoding a protein that regulates ras1. Cell Regul (1991) 1.20
Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet (1993) 1.19
Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genomics (2011) 1.17
Characterization of a guanine nucleotide-releasing factor and a GTPase-activating protein that are specific for the ras-related protein p25rab3A. Proc Natl Acad Sci U S A (1992) 1.17
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol (1994) 1.14
A role for Pak protein kinases in Schwann cell transformation. Proc Natl Acad Sci U S A (1998) 1.14
Mast cells and the neurofibroma microenvironment. Blood (2010) 1.13
The pathoetiology of neurofibromatosis 1. Am J Pathol (2011) 1.13
The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH. Mol Cell Biol (1991) 1.13
Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A (2010) 1.12
Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J (1993) 1.11
Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation. Mol Cell Biol (1992) 1.08
Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A (1991) 1.08
Identification of a GTPase-activating protein homolog in Schizosaccharomyces pombe. Mol Cell Biol (1991) 1.08
A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn (2011) 1.08
The biochemistry of ras p21. Biochem J (1991) 1.08
Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein. Mol Cell Biol (2006) 1.07
Circadian regulation of cGMP-gated channels of vertebrate cone photoreceptors: role of cAMP and Ras. J Neurosci (2004) 1.07
Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. J Exp Med (1994) 1.06
Linking yeast genetics to mammalian genomes: identification and mapping of the human homolog of CDC27 via the expressed sequence tag (EST) data base. Proc Natl Acad Sci U S A (1993) 1.05
Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene. Hum Mol Genet (2010) 1.04
The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans. Mol Cell Biol (2010) 1.03
Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis. Sci Signal (2013) 1.03
Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression. Mol Cell Biol (1994) 1.01
Broad issues to consider for library involvement in bioinformatics. J Med Libr Assoc (2006) 0.98
Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells. Oncogene (2004) 0.98
Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol (2009) 0.97
Overexpression of RPI1, a novel inhibitor of the yeast Ras-cyclic AMP pathway, down-regulates normal but not mutationally activated ras function. Mol Cell Biol (1991) 0.96
A gene encoding a protein with seven zinc finger domains acts on the sexual differentiation pathways of Schizosaccharomyces pombe. Mol Biol Cell (1992) 0.96
The plexiform neurofibroma microenvironment. Cancer Microenviron (2012) 0.95
Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1. Neurosci Lett (2012) 0.95
Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Hum Mol Genet (2008) 0.94
Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction. Mol Cell Biol (1993) 0.94
Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis. Am J Pathol (2014) 0.93
Developmental regulation and neuronal expression of the mRNA of rat n-chimaerin, a p21rac GAP:cDNA sequence. Biochem J (1992) 0.93
Pathogenesis of vascular anomalies. Clin Plast Surg (2011) 0.93
Classical oncogenes and tumor suppressor genes: a comparative genomics perspective. Neoplasia (2000) 0.93
Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways. PLoS One (2012) 0.93
Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics (2007) 0.92
The NF1 gene revisited - from bench to bedside. Oncotarget (2014) 0.91
Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol (2016) 0.91
Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest (1993) 0.91
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol (2011) 0.91
Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions. Proc Natl Acad Sci U S A (1993) 0.91
Monozygotic twins discordant for neurofibromatosis 1. Am J Med Genet A (2010) 0.91
The ability of GAP1IP4BP to function as a Rap1 GTPase-activating protein (GAP) requires its Ras GAP-related domain and an arginine finger rather than an asparagine thumb. Mol Cell Biol (2009) 0.91
Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration. Stem Cells (2012) 0.91
Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. Mol Cancer Ther (2011) 0.90
A dominant activating mutation in the effector region of RAS abolishes IRA2 sensitivity. Mol Cell Biol (1992) 0.90
Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells. Mol Cell Biol (1997) 0.90
Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells. Curr Opin Hematol (2010) 0.89
Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation. Hum Mol Genet (2014) 0.89
The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res (2009) 0.89
Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. Nucleic Acids Res (2000) 0.89
Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brain Res Bull (2011) 0.88
Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes. Mol Cell Biol (1994) 0.88
Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis. Oncotarget (2013) 0.88
Regulation of yeast G protein signaling by the kinases that activate the AMPK homolog Snf1. Sci Signal (2013) 0.88
NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut (2005) 0.88
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell (1979) 21.15
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell (1978) 19.44
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
Functional homology of mammalian and yeast RAS genes. Cell (1985) 14.01
Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol (1988) 13.78
Effects of the obese gene product on body weight regulation in ob/ob mice. Science (1995) 13.57
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell (1985) 11.63
Cloning the differences between two complex genomes. Science (1993) 10.60
Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell (1996) 10.40
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res (1991) 9.56
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
GenBank. Nucleic Acids Res (1996) 7.06
Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins. Cell (1984) 6.87
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature (1982) 6.78
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 6.73
Genetic and physical linkage of exogenous sequences in transformed cells. Cell (1980) 6.67
Genetic analysis of yeast RAS1 and RAS2 genes. Cell (1984) 6.60
The transfer and stable integration of the HSV thymidine kinase gene into mouse cells. Cell (1978) 6.38
Three different genes in S. cerevisiae encode the catalytic subunits of the cAMP-dependent protein kinase. Cell (1987) 6.35
GenBank. Nucleic Acids Res (1994) 5.63
Functional genomics: it's all how you read it. Science (1997) 5.34
Structure and activation of the human N-ras gene. Cell (1983) 5.25
Cloning and characterization of BCY1, a locus encoding a regulatory subunit of the cyclic AMP-dependent protein kinase in Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.03
DNA sequence and characterization of the S. cerevisiae gene encoding adenylate cyclase. Cell (1985) 4.80
The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway. Cell (1987) 4.74
Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature (1983) 4.44
The somatic replication of DNA methylation. Cell (1981) 4.42
Isolation of the chicken thymidine kinase gene by plasmid rescue. Nature (1980) 4.37
Complex formation between RAS and RAF and other protein kinases. Proc Natl Acad Sci U S A (1993) 4.30
Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature (1982) 4.30
Human-tumor-derived cell lines contain common and different transforming genes. Cell (1981) 4.29
Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins. Cell (1985) 4.23
The National Center for Biotechnology Information. Genomics (1990) 4.01
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
cAMP-independent control of sporulation, glycogen metabolism, and heat shock resistance in S. cerevisiae. Cell (1988) 3.72
Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell. Cell (1980) 3.66
Analysis of the transforming potential of the human H-ras gene by random mutagenesis. Proc Natl Acad Sci U S A (1984) 3.64
Expectations and high school change: teacher-researcher collaboration to prevent school failure. Am J Community Psychol (1991) 3.62
RAM, a gene of yeast required for a functional modification of RAS proteins and for production of mating pheromone a-factor. Cell (1986) 3.57
Introduction and expression of a rabbit beta-globin gene in mouse fibroblasts. Proc Natl Acad Sci U S A (1979) 3.53
Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc Natl Acad Sci U S A (1983) 3.52
New human transforming genes detected by a tumorigenicity assay. Mol Cell Biol (1984) 3.43
Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc Natl Acad Sci U S A (1980) 3.39
ras proteins can induce meiosis in Xenopus oocytes. Cell (1985) 3.23
Cloning and characterization of the high-affinity cAMP phosphodiesterase of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1986) 3.19
Genes, themes and microarrays: using information retrieval for large-scale gene analysis. Proc Int Conf Intell Syst Mol Biol (2000) 3.01
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell (1986) 2.65
Tumour promotor induces plasminogen activator. Nature (1976) 2.60
Rigorous feedback control of cAMP levels in Saccharomyces cerevisiae. Genes Dev (1987) 2.58
Dominant yeast and mammalian RAS mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae. Mol Cell Biol (1989) 2.57
SCH9, a gene of Saccharomyces cerevisiae that encodes a protein distinct from, but functionally and structurally related to, cAMP-dependent protein kinase catalytic subunits. Genes Dev (1988) 2.57
Complexes between STE5 and components of the pheromone-responsive mitogen-activated protein kinase module. Proc Natl Acad Sci U S A (1994) 2.53
A method for difference cloning: gene amplification following subtractive hybridization. Proc Natl Acad Sci U S A (1990) 2.53
Genetic analysis using genomic representations. Proc Natl Acad Sci U S A (1998) 2.52
byr2, a Schizosaccharomyces pombe gene encoding a protein kinase capable of partial suppression of the ras1 mutant phenotype. Mol Cell Biol (1991) 2.48
Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae. Mol Cell Biol (1987) 2.45
Genetic analysis of mammalian GAP expressed in yeast. Cell (1989) 2.44
Complex synthetic chemical libraries indexed with molecular tags. Proc Natl Acad Sci U S A (1993) 2.44
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Isolation and characterization of a mammalian gene encoding a high-affinity cAMP phosphodiesterase. Proc Natl Acad Sci U S A (1989) 2.31
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae. Mol Cell Biol (1987) 2.25
A product of yeast RAS2 gene is a guanine nucleotide binding protein. Proc Natl Acad Sci U S A (1984) 2.24
Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc Natl Acad Sci U S A (1987) 2.11
Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells. J Mol Appl Genet (1983) 2.09
Functional homology of protein kinases required for sexual differentiation in Schizosaccharomyces pombe and Saccharomyces cerevisiae suggests a conserved signal transduction module in eukaryotic organisms. Mol Biol Cell (1993) 2.09
Remarkable conservation of structure among intermediate filament genes. Cell (1984) 2.07
Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis (1998) 2.07
Evidence for a functional link between profilin and CAP in the yeast S. cerevisiae. Cell (1991) 2.05
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03
Oncogenic ras triggers the activation of 42-kDa mitogen-activated protein kinase in extracts of quiescent Xenopus oocytes. Proc Natl Acad Sci U S A (1992) 2.02
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res (2000) 1.99
CAP is a bifunctional component of the Saccharomyces cerevisiae adenylyl cyclase complex. Mol Cell Biol (1991) 1.98
SNC1, a yeast homolog of the synaptic vesicle-associated membrane protein/synaptobrevin gene family: genetic interactions with the RAS and CAP genes. Proc Natl Acad Sci U S A (1992) 1.97
Characterization of an activated human ros gene. Mol Cell Biol (1986) 1.97
Mutations of the adenylyl cyclase gene that block RAS function in Saccharomyces cerevisiae. Science (1990) 1.91
A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol Cell Biol (1993) 1.90
A medium-density genetic linkage map of the bovine genome. Mamm Genome (1997) 1.85
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol (2000) 1.79
Influence of guanine nucleotides on complex formation between Ras and CDC25 proteins. Mol Cell Biol (1993) 1.78
Complete sequence of a gene encoding a human type I keratin: sequences homologous to enhancer elements in the regulatory region of the gene. Proc Natl Acad Sci U S A (1985) 1.78
Purification and characterization of human H-ras proteins expressed in Escherichia coli. Mol Cell Biol (1985) 1.77
The adenylyl cyclase gene from Schizosaccharomyces pombe. Proc Natl Acad Sci U S A (1989) 1.73
Characterization of ROS1 cDNA from a human glioblastoma cell line. Proc Natl Acad Sci U S A (1990) 1.73
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun (1999) 1.63
Type I and type II keratins have evolved from lower eukaryotes to form the epidermal intermediate filaments in mammalian skin. Proc Natl Acad Sci U S A (1983) 1.61
Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science (1991) 1.58
Genetic information and the workplace: legislative approaches and policy changes. Science (1997) 1.56
Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J Biol Chem (1993) 1.53
Chromosomal assignment of a family of human oncogenes. Proc Natl Acad Sci U S A (1983) 1.53
Induction of neurite outgrowth by a conditioned-medium factor bound to the culture substratum. Proc Natl Acad Sci U S A (1978) 1.52
Purification, cloning, and expression of ciliary neurotrophic factor (CNTF). Science (1989) 1.50
In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol (2001) 1.49
Representational difference analysis in detection of genetic lesions in cancer. Methods Enzymol (1995) 1.46
Mutational mapping of RAS-responsive domains of the Saccharomyces cerevisiae adenylyl cyclase. Mol Cell Biol (1990) 1.44